SUZ Suzano S.A.

NEUTRAL Impact: 4/10 6-K
Horizon weeks Filed May 28, 2026 Processed 12d 19h ago SEC 0001628280-26-038610
Notable filing: 6-K
Latest settled — T+5d
SUZ ▼ -2.78% at T+5d
NEUTRAL call ✗ call lost -2.78% · α vs SPY -3.10% · entry $8.26 → $8.03
Next anchor: T+20d in 16d
Last close $8.12 (close Jun 8) · -1.69% from $8.26 entry
Entry anchored
May 28, 2026
via day open
T+1d
-0.97%
call -0.97% · α -1.21%
$8.18
settled 12d ago
T+5d
-2.78%
call -2.78% · α -3.10%
$8.03
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Suzano announced that all regulatory antitrust approvals have been obtained for its previously announced JV with Kimberly-Clark to acquire a 51% stake in a new tissue-products company spanning multiple regions. Closing remains subject to K-C's corporate reorganization and is expected in Q3 2026. This removes a key condition precedent but does not guarantee closing, keeping the deal on track but not yet consummated.

Actionable Insight

Monitor for completion of K-C's corporate reorganization, which is the remaining condition for closing. Deal timing (Q3 2026) unchanged — no incremental catalyst until closure. Stock likely to trade on broader pulp/tissue fundamentals rather than this procedural update.

Key Facts

  • All antitrust approvals for the K-C JV acquisition have been obtained.
  • Closing subject to completion of K-C's corporate reorganization across South America, Central America, Ireland, UK, Europe, Africa, Middle East, Asia, and Oceania.
  • Closing expected in Q3 2026, consistent with prior guidance.
  • Suzano to hold 51% equity interest in the Target Company; K-C to hold the remaining 49%.
  • Target Company will hold tissue product assets (toilet paper, paper towels, napkins, facial tissues) in the Included Regions, excluding certain countries.

Financial Impact

No financial terms disclosed in the filing; the deal structure, purchase price, and financial impact remain undisclosed.

Risk Factors

  • Deal closure delayed if K-C reorganization is not completed in Q3 2026 as expected.
  • No deal consideration disclosed — market cannot price the earnings accretion/dilution impact.
  • Integration risk post-closing for expanded tissue operations across multiple regions.

Market Snapshot

Exchange
NYSE
Sector
Paper Mills
Analyst Consensus
91% bullish (22 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-038610
Document: a20260528-suzano_materialf.htm0001628280-26-038610
Document: 0001628280-26-038610-index-headers.html0001628280-26-038610
Document: 0001628280-26-038610-index.html0001628280-26-038610
Document: 0001628280-26-038610.txt0001628280-26-038610
6 reports for SUZ
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SUZ — sortable, filterable
Type Now
May 28, 2026
12d ago
6-K
NEUTRAL ★ 4/10
$8.26 $8.03▼ −2.78%▼ −3.10%$8.12 (−1.69%)
May 11, 2026
29d ago
6-K
NEUTRAL ★ 4/10
$8.75 $8.37▼ −4.34%▼ −4.42%$8.12 (−7.20%)
May 7, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$8.87 $8.54▼ −3.72%▼ −5.18%$8.12 (−8.46%)
Apr 30, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$8.87 $8.74▼ −1.47%▼ −3.19%$8.12 (−8.46%)
Apr 29, 2026
5w ago
6-K
BEARISH ★ 6/10
$8.87 $8.74▲ +1.47%▲ +3.19%$8.12 (+8.46%)
Apr 24, 2026
6w ago
6-K
NEUTRAL ★ 1/10
$9.10 $8.55▼ −6.04%▼ −6.44%$8.12 (−10.77%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 7h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access